FDA.reportPublic FDA data

Viread 300 MG Oral Tablet

RxCUI
352050
RxNorm name
Viread 300 MG Oral Tablet
Display name
Viread 300 MG Oral Tablet
Full name
Viread 300 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VireadTENOFOVIR DISOPROXIL FUMARATEGilead Sciences, Inc.33fd6418-fbdc-42ca-a50d-ce2a476a54182025-02-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 352050

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
33fd6418-fbdc-42ca-a50d-ce2a476a5418Viread 300 MG Oral Tablet [PSN] · tenofovir disoproxil fumarate 300 MG Oral Tablet [Viread] [SBD] · Viread 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet [SY] · Viread 300 MG Oral Tablet [SY]431These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 200120250218
1fdae465-2c01-4030-a73c-fd2f13368453Viread 300 MG Oral Tablet [PSN] · tenofovir disoproxil fumarate 300 MG Oral Tablet [Viread] [SBD] · Viread 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet [SY] · Viread 300 MG Oral Tablet [SY]411These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. GILEAD ACCESS PROGRAM VIREAD™ (tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 200120260213
d3d0b5ef-8226-49d6-ab66-987943413cccViread 300 MG Oral Tablet [PSN] · tenofovir disoproxil fumarate 300 MG Oral Tablet [Viread] [SBD] · Viread 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet [SY] · Viread 300 MG Oral Tablet [SY]41These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 200120151124
e122435e-cd0b-4c90-940a-b7a0d090d866Viread 300 MG Oral Tablet [PSN] · tenofovir disoproxil fumarate 300 MG Oral Tablet [Viread] [SBD] · Viread 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral Tablet [SY] · Viread 300 MG Oral Tablet [SY]41These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD (tenofovir disoproxil fumarate) tablet, coated for oral use Initial U.S. Approval: 200120100413